• About Amgen
  • Science
  • Corporate Giving
  • Site Map
  • Search
  • Privacy & Terms
  • Contact Us
  • Patients
  • Medical Professionals
  • Partners
  • Investors
  • Careers
  • Media
  • print
  • mail
  • Home
  • Pharmacy Affairs
  • Emerging Science

  • Overview
  • Product Sites
  • Pharmacy Assoc. and Conferences
  • Resources
  • Education for Pharmacists
  • Emerging Science
  • Newsletter
Emerging Science
Amgen Innovation

As the world's largest biotechnology company, Amgen leverages innovative science and unique discoveries in molecular biology to create many of the most effective treatments for people fighting cancer. We constantly strive to extend the frontiers of cancer research and treatment. To read more click on the hyper link above

Amgen Science

We aspire to be the best human therapeutics company. Achieving our goal starts with building the best R&D organization. Our R&D engine is powered by dedicated, creative scientists who are attracted to Amgen by our intellectual vigor, our commitment to world-class research, and most importantly, by the many opportunities we offer to make a dramatic difference in the lives of patients. To read more click on the hyper link above.

Emerging Science

To read more click on the hyper link above.

 


  • Prescribing Information
  • Aranesp® (darbepoetin alfa) Prescribing Information
  • Enbrel® (etanercept) Prescribing Information
  • EPOGEN® (Epoetin alfa) Prescribing Information
  • Kepivance® (palifermin) Prescribing Information
  • Kineret® (anakinra) Prescribing Information
  • Neulasta® (pegfilgrastim) Prescribing Information
  • NEUPOGEN® (Filgrastim) Prescribing Information
  • Sensipar® (cinacalcet HCl) Prescribing Information
  • Vectibix® (panitumumab) Prescribing Information
  • Related Links
  • AmgenOncology.com
footer